Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $518208.0.

  • Dare Bioscience's Change in Account Payables rose 16018.12% to $518208.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $773280.0, marking a year-over-year increase of 11963.28%. This contributed to the annual value of -$1.9 million for FY2024, which is 24214.17% down from last year.
  • According to the latest figures from Q3 2025, Dare Bioscience's Change in Account Payables is $518208.0, which was up 16018.12% from -$120543.0 recorded in Q2 2025.
  • Dare Bioscience's 5-year Change in Account Payables high stood at $3.8 million for Q2 2023, and its period low was -$2.1 million during Q2 2024.
  • For the 5-year period, Dare Bioscience's Change in Account Payables averaged around $42138.3, with its median value being $389689.0 (2021).
  • As far as peak fluctuations go, Dare Bioscience's Change in Account Payables plummeted by 78767.37% in 2021, and later skyrocketed by 50637.17% in 2022.
  • Over the past 5 years, Dare Bioscience's Change in Account Payables (Quarter) stood at $1.5 million in 2021, then plummeted by 196.79% to -$1.4 million in 2022, then dropped by 10.53% to -$1.6 million in 2023, then soared by 125.42% to $407154.0 in 2024, then increased by 27.28% to $518208.0 in 2025.
  • Its Change in Account Payables was $518208.0 in Q3 2025, compared to -$120543.0 in Q2 2025 and -$31539.0 in Q1 2025.